Explore our featured news items here. Subscribe to stay informed of all information shared and published by OHC.
Sponsor appreciation:
You’re invited to explore and join Physician Factor, a knowledge exchange network is a dedicated portal for physicians seeking opportunities to contribute their expertise and input in exchange for compensation and supplemental income.
You can search articles using your own keywords or the following tags: Lung Cancer | Breast Cancer | Drugs and Therapies | Cancer General
Alcohol's Link to Cancer: A Growing Concern
Despite the common perception that moderate drinking is harmless, the U.S. Surgeon General has issued a stark warning: no amount of alcohol is safe without increasing cancer risk. Alcohol is now the third leading preventable cause of cancer in the U.S., contributing to a higher risk of at least seven types of cancer.
Breast Cancer Increasing Among Younger Women, Latest Data Show
A recent report from the American Cancer Society highlights concerning trends in breast cancer, with rates rising by 1% annually between 2012 and 2021, particularly among younger women and Asian American and Pacific Islander populations. Despite advances in early detection and treatment, the disease remains the second leading cause of cancer death in women, with significant racial and ethnic disparities in outcomes still persisting.
November is Lung Cancer Awareness Month: Join the AACR in Advancing Research for Prevention and Treatment
November is Lung Cancer Awareness Month, highlighting the urgent need for research and action to prevent and treat lung cancer, the leading cause of cancer death in the United States. The AACR is actively supporting groundbreaking research and advocating for policies to reduce smoking-related cancers and improve outcomes for those diagnosed with the disease.
Emerging Use of Weight Loss Drugs in Cancer Treatment
Recent interest suggests that these antiobesity drugs could play a role in cancer care. Although data supporting the use of GLP-1 agonists for weight loss in cancer patients is limited, some oncologists are beginning to explore their application and study their effects.
A New Artificial Intelligence Tool for Cancer
Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers.
Screening People at High Risk for Pancreatic Cancer May Help Them Live Longer
For people who are at high risk of developing pancreatic cancer, regular imaging tests to monitor the pancreas may help detect the disease at an earlier stage than when pancreatic cancer is typically diagnosed in the general population, according to a new study.
Oncologists Should Re-Evaluate Cancer Treatments Near End of Life
Systemic treatment of cancer patients near end of life does not improve survival rates, according to a new study from researchers at Yale Cancer Center (YCC) and the University of Texas MD Anderson Cancer Center.
Evolving Treatment Paradigms in Multiple Myeloma Could Improve Patient Outcomes
The second most common blood cancer, is shifting rapidly, with newly diagnosed patients increasingly being treated with a four-part drug combination that includes a new immunotherapy agent.
Virtual Reality Is a Tool for Education, Relaxation for Nurses and Patients
Simulated experiences using virtual reality (VR) can help oncology nurses alleviate a patient’s anxiety before undergoing treatment, provide comfort in palliative care settings, and serve as an educational tool for both nurses and patients.
Oncologist Burnout Could Be Rising for These Reasons
While other physician specialties have seen a decline in burnout, oncologists are reporting slightly higher rates of burnout. Medscape's "Physician Burnout and Depression Report 2024" surveyed 9,226 physicians across 29 specialties between July 5 and Oct. 9. In the rankings, 53% of oncologists said they experienced burnout. This is a 1% increase over the 2023 report, though oncologists jumped to the second-most burned out specialty, up from the 12th spot in 2023.
How Serious Is FDA Warning About Revolutionary Blood-Cancer Treatment?
The Food and Drug Administration announced in December 2023 that it’s investigating reports of secondary cancers in patients who received CAR T-cell therapy, one of a suite of immunotherapies that have revolutionized cancer care over the past decade. The treatment reprograms a patient’s T cells, a key part of the immune system, to recognize and attack cancer cells.
Clinical Biomarkers Are the Key to Precision Medicine in Prostate Cancer
Current treatment approaches increasingly rely on cancer biomarkers to gain information about a patient's cancer to predict which treatment may work best for them, a practice known as precision medicine. At a fundamental level, precision medicine focuses on selecting the right treatment, for the right patient, at the right time to optimize health outcomes. Precision medicine looks at genetics, the environment, and lifestyle of a patient and accounts for specific information about the cancerous tumor to aide in diagnosis, estimate prognosis, select therapy, and monitor the efficacy of treatment.
Diet and Exercise Interventions Improve Chemotherapy Outcomes for Women With Breast Cancer: Study
A new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer. In the study, published September 1 in the Journal of Clinical Oncology, women recently diagnosed with breast cancer targeted were offered interventions aimed at adopting dietary and physical activity guidelines with the goal of fighting chemotoxicity and improving therapy adherence.
Scientists Employ AI To Predict Brain Cancer Outcomes
Stanford Medicine scientists and colleagues create an algorithm that could help physicians better understand and target complicated brain tumors.